More than 2,600 people may have been exposed to tuberculosis at Sheba Medical Center in Ramat Gan, Israel, between March 17 and March 22, 2026, according to a joint statement released Sunday evening by the Health Ministry and the hospital. The exposure stemmed from a patient diagnosed with pulmonary tuberculosis who was hospitalized in the underground complex, specifically the surgical area located beneath the gynecological and maternity ward. The situation has prompted a large-scale epidemiological investigation and a tiered response plan to mitigate potential infections.
The potential exposure includes approximately 750 patients, a particularly vulnerable group encompassing around 300 newborns and infants under one year old, as well as individuals with compromised immune systems. Around 1,900 staff members were too present in the affected area during the period in question, along with an undetermined number of visitors and accompanying persons. The Health Ministry is emphasizing that while tuberculosis is an airborne illness, the risk of infection is primarily associated with prolonged exposure – generally defined as more than 6-8 hours – and is treatable with antibiotics.
Understanding Tuberculosis and the Risk of Exposure
Tuberculosis (TB) is caused by the bacterium Mycobacterium tuberculosis, which typically attacks the lungs, but can affect other parts of the body as well. The Centers for Disease Control and Prevention (CDC) explains that TB is spread through the air when a person with active TB disease coughs, speaks, sings, or sneezes, releasing tiny droplets containing the bacteria. Learn more about tuberculosis from the CDC.
Not everyone infected with TB bacteria will develop active disease. Many individuals harbor a latent TB infection, meaning the bacteria are present in their bodies but are inactive and cause no symptoms. However, latent TB can become active, particularly in people with weakened immune systems. Symptoms of active TB disease include a persistent cough, often producing sputum, fever, night sweats, weight loss, and fatigue. Early detection and treatment are crucial to prevent the spread of the disease and avoid serious complications.
Sheba Medical Center’s Response and Testing Protocol
Sheba Medical Center has affirmed its full cooperation with the Health Ministry in addressing the exposure incident. The hospital stated it is adhering to all ministry guidelines and will continue to monitor the situation closely. The Health Ministry has outlined a specific testing and treatment protocol based on risk level.
Patients and staff who were present in the affected area will be instructed to undergo a tuberculin skin test (also known as the Mantoux test) to determine if they have been infected. A positive test result will be followed by preventive antibiotic treatment. However, the most vulnerable populations – infants under three years of age and individuals with weakened immune systems – will receive immediate antibiotic treatment for four months, without the need for prior skin testing. This proactive approach aims to prevent the development of active TB disease in those most susceptible to severe illness.
Who Needs to Capture Action?
The Health Ministry is urging visitors and accompanying persons who spent a cumulative total of more than eight hours in the affected area between March 17 and March 22, 2026, to contact the ministry’s hotline at *5400 for further instructions. This includes anyone who may have accompanied patients or waited in the surgical area beneath the gynecological and maternity ward.
The ministry is also working to directly contact individuals identified through hospital records. However, reaching all visitors and accompanying persons presents a challenge, and self-reporting is crucial to ensure comprehensive coverage. The Health Ministry has not yet released specific details on the type of antibiotic being used for preventative treatment, but emphasized it will follow established clinical guidelines.
While the scale of the potential exposure is significant, health officials are emphasizing that the risk of infection is dependent on the duration and proximity of exposure. The swift response and targeted testing and treatment plan are designed to minimize the impact of this incident and protect the health of those potentially affected.
The Health Ministry will continue to monitor the situation and provide updates to the public as more information becomes available. Individuals with concerns about potential TB exposure are encouraged to consult with their healthcare providers.
Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
The next update from the Health Ministry regarding the results of the initial testing phase is expected within the next two weeks. We will continue to follow this developing story and provide updates as they become available. Please share this information with anyone who may have been affected and abandon your questions and comments below.
